ETF Managers Group’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

ETF Managers Group’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$26K	Buy	2,858 +712	+33%	+$10.1K	﹤0.01%	672
2022 Q4	$25.2K	Sell	2,146 -394	-16%	-$6.95K	﹤0.01%	508
2022 Q3	$54K	Sell	2,540 -180	-7%	-$4.85K	﹤0.01%	670
2022 Q2	$67K	Buy	2,720 +118	+5%	+$4.02K	﹤0.01%	696
2022 Q1	$130K	Buy	2,602 +9	+0.3%	+$445	﹤0.01%	621
2021 Q4	$187K	Sell	2,593 -296	-10%	-$24.9K	﹤0.01%	615
2021 Q3	$268K	Sell	2,889 -2,109	-42%	-$200K	0.01%	599
2021 Q2	$558K	Sell	4,998 -190	-4%	-$18.5K	0.01%	514
2021 Q1	$459K	Sell	5,188 -2,661	-34%	-$270K	0.01%	479
2020 Q4	$711K	Sell	7,849 -823	-9%	-$70.2K	0.02%	280
2020 Q3	$775K	Buy	8,672 +6,424	+286%	+$749K	0.02%	240
2020 Q2	$211K	Buy	+2,248	New	+$124K	0.01%	554

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ETF Managers Group's VBIV Position: Q1 2023 in Review

ETF Managers Group increased its VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) stake by 33% in Q1 2023, buying an estimated $10.1K and bringing the position to 2,858 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #672.

ETF Managers Group first reported a position in VBIV in Q2 2020 and has held it in 12 quarters since. The position peaked at $775K in Q3 2020. 95 funds tracked by Wall St. Rank hold VBIV as of Q1 2023.

ETF Managers Group held 2,858 shares of VBI Vaccines, Inc. New Common Stock (Canada) worth $26K as of Q1 2023.
ETF Managers Group bought 712 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2023, an estimated $10.1K.
VBI Vaccines, Inc. New Common Stock (Canada) made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #672 holding.
ETF Managers Group first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2020 and has held it in 12 quarters since.
ETF Managers Group's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $775K in Q3 2020.
95 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.